Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Nat Rev Endocrinol ; 13(9): 509-520, 2017 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-28621339

RESUMO

Hepatic steatosis is an underlying feature of nonalcoholic fatty liver disease (NAFLD), which is the most common form of liver disease and is present in up to ∼70% of individuals who are overweight. NAFLD is also associated with hypertriglyceridaemia and low levels of HDL, glucose intolerance, insulin resistance and type 2 diabetes mellitus. Hepatic steatosis is a strong predictor of the development of insulin resistance and often precedes the onset of other known mediators of insulin resistance. This sequence of events suggests that hepatic steatosis has a causal role in the development of insulin resistance in other tissues, such as skeletal muscle. Hepatokines are proteins that are secreted by hepatocytes, and many hepatokines have been linked to the induction of metabolic dysfunction, including fetuin A, fetuin B, retinol-binding protein 4 (RBP4) and selenoprotein P. In this Review, we describe the factors that influence the development of hepatic steatosis, provide evidence of strong links between hepatic steatosis and insulin resistance in non-hepatic tissues, and discuss recent advances in our understanding of how steatosis alters hepatokine secretion to influence metabolic phenotypes through inter-organ communication.


Assuntos
Proteínas Sanguíneas/fisiologia , Resistência à Insulina , Fígado/fisiopatologia , Hepatopatia Gordurosa não Alcoólica/fisiopatologia , Animais , Diabetes Mellitus Tipo 2 , Dieta Hiperlipídica , Fetuína-B/fisiologia , Humanos , Hipertrigliceridemia , Metabolismo dos Lipídeos/fisiologia , Obesidade , Sobrepeso , Proteínas Plasmáticas de Ligação ao Retinol/fisiologia , Selenoproteína P/fisiologia , alfa-2-Glicoproteína-HS/fisiologia
2.
Biol Chem ; 395(10): 1195-9, 2014 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-25205729

RESUMO

The zona pellucida, a glycoprotein matrix surrounding the mammalian oocyte, hardens after intrusion of the first spermatozoon, thus protecting the embryo until implantation and preventing multiple fertilizations (polyspermy). Definitive zona hardening is mediated by the metalloprotease ovastacin, which is released from cortical granules of the oocyte upon sperm penetration. However, traces of ovastacin seep from unfertilized eggs to cause zona hardening even in the absence of sperm. These small amounts of protease are inactivated by the plasma protein fetuin-B, thus keeping eggs fertilizable. Once a sperm has penetrated the egg, ovastacin from cortical vesicles overrides fetuin-B and initiates zona hardening.


Assuntos
Fetuína-B/fisiologia , Células Germinativas/fisiologia , Metaloproteases/antagonistas & inibidores , Animais , Feminino , Fertilidade , Fertilização , Humanos , Gravidez , Interações Espermatozoide-Óvulo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...